These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 18589449)

  • 41. [Practical attitude toward arrhythmia in the neonate and infant].
    Lupoglazoff JM; Denjoy I
    Arch Pediatr; 2004 Oct; 11(10):1268-73. PubMed ID: 15475291
    [TBL] [Abstract][Full Text] [Related]  

  • 42. QTc-interval abnormalities in a forensic population.
    Girgis S; Huckstep B; Oakley J; Ferriter M; Nikolaou V
    Crim Behav Ment Health; 2007; 17(2):75-88. PubMed ID: 17295199
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prolong QT interval and "torsades de pointes" associated with different group of drugs.
    Gongadze N; Kezeli T; Antelava N
    Georgian Med News; 2007 Dec; (153):45-9. PubMed ID: 18250496
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Survey of the use of domperidone and the association with QTc prolongation in general practice.
    Ioannou A; Jain A; Kassianos G; Missouris C
    Postgrad Med J; 2016 Jul; 92(1089):390-2. PubMed ID: 26802127
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases--a multicentre prospective study.
    Gerosa M; Cimaz R; Stramba-Badiale M; Goulene K; Meregalli E; Trespidi L; Acaia B; Cattaneo R; Tincani A; Motta M; Doria A; Zulian F; Milanesi O; Brucato A; Riboldi P; Meroni PL
    Rheumatology (Oxford); 2007 Aug; 46(8):1285-9. PubMed ID: 17449486
    [TBL] [Abstract][Full Text] [Related]  

  • 46. QTc prolongation associated with combination therapy of levofloxacin, imipramine, and fluoxetine.
    Nykamp DL; Blackmon CL; Schmidt PE; Roberson AG
    Ann Pharmacother; 2005 Mar; 39(3):543-6. PubMed ID: 15687478
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prolonged QTc interval in children and young adults with sickle cell disease at steady state.
    Liem RI; Young LT; Thompson AA
    Pediatr Blood Cancer; 2009 Jul; 52(7):842-6. PubMed ID: 19229972
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Psychotropic drugs associated with corrected QT interval prolongation.
    van Noord C; Straus SM; Sturkenboom MC; Hofman A; Aarnoudse AJ; Bagnardi V; Kors JA; Newton-Cheh C; Witteman JC; Stricker BH
    J Clin Psychopharmacol; 2009 Feb; 29(1):9-15. PubMed ID: 19142100
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence of long QTc interval in methadone maintenance patients.
    Fonseca F; Marti-Almor J; Pastor A; Cladellas M; Farré M; de la Torre R; Torrens M
    Drug Alcohol Depend; 2009 Jan; 99(1-3):327-32. PubMed ID: 18774239
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Magnitude of QT prolongation associated with a higher risk of Torsades de Pointes.
    Lin YL; Kung MF
    Pharmacoepidemiol Drug Saf; 2009 Mar; 18(3):235-9. PubMed ID: 19145580
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Domperidone and long QT syndrome.
    Rossi M; Giorgi G
    Curr Drug Saf; 2010 Jul; 5(3):257-62. PubMed ID: 20394569
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Takotsubo cardiomyopathy and QT interval prolongation: who are the patients at risk for torsades de pointes?
    Samuelov-Kinori L; Kinori M; Kogan Y; Swartzon M; Shalev H; Guy D; Ferenidou F; Mashav N; Sadeh B; Atzmony L; Kliuk-Ben-Basat O; Steinvil A; Justo D
    J Electrocardiol; 2009; 42(4):353-357.e1. PubMed ID: 19261294
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cesium-induced QT-interval prolongation in an adolescent.
    O'Brien CE; Harik N; James LP; Seib PM; Stowe CD
    Pharmacotherapy; 2008 Aug; 28(8):1059-65. PubMed ID: 18657021
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Cardiac adverse effects of domperidone in adult patients: a systematic review].
    Marzi M; Weitz D; Avila A; Molina G; Caraballo L; Piskulic L
    Rev Med Chil; 2015 Jan; 143(1):14-21. PubMed ID: 25860264
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Cisapride and risk of cardiac complications].
    Cataldo F
    Minerva Pediatr; 1999; 51(9-10):309-11. PubMed ID: 10783591
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Domperidone: limited benefits with significant risk for sudden cardiac death.
    Hondeghem LM
    J Cardiovasc Pharmacol; 2013 Mar; 61(3):218-25. PubMed ID: 23188128
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiac safety concerns for domperidone, an antiemetic and prokinetic, and galactogogue medicine.
    Doggrell SA; Hancox JC
    Expert Opin Drug Saf; 2014 Jan; 13(1):131-8. PubMed ID: 24147629
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of ANOVA to estimate inter- and intra-reader variability for a group of readers in thorough QT/QTc studies.
    Natekar M; Mahajan V; Satra A; O'Kelly M; Karnad DR
    Clin Pharmacol Ther; 2008 Mar; 83(3):489-91. PubMed ID: 18183035
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Calcium channel blockers, NOS1AP, and heart-rate-corrected QT prolongation.
    van Noord C; Aarnoudse AJ; Eijgelsheim M; Sturkenboom MC; Straus SM; Hofman A; Kors JA; Newton-Cheh C; Witteman JC; Stricker BH
    Pharmacogenet Genomics; 2009 Apr; 19(4):260-6. PubMed ID: 19247217
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pilot Study on QTc Interval in Dogs Treated with Domperidone.
    Donato G; Caspanello T; De Majo M; Masucci M; Iannelli D; Santoro S; Caprì A; Iannelli NM; Pennisi MG
    Vet Sci; 2024 Jan; 11(1):. PubMed ID: 38250945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.